Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Biohacking Market Analysis & Forecast to 2024-2034: Market By Product; By Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering.
The biohacking domain is seemingly undergoing a profound transformation, with the global biohacking market poised for substantial growth. This industry analysis reveals promising figures, projecting the market's expansion from USD 26.28 billion in 2023 to an estimated USD 185.13 billion by 2034, at a CAGR of 19.42% from 2024 to 2034.
Highlighting Key Market Segments:
- By Product: The demand for wearable technologies remains ascendant, attributing to the segment's highest revenue share in 2023.
- By Application: Monitoring applications have dominated market revenue, backed by advanced wearable and implantable biohacking devices.
- By End-user: Hospitals and clinics emerge as the leading end-users of biohacking technologies, due to a pressing need for innovative treatments and diagnostics.
An in-depth analysis of the biohacking market by region underscores North America's dominance, credited to robust R&D investments and a proliferation of new products designed to augment cognitive and physical well-being. On the horizon, the Asia-Pacific region showcases the fastest growth potential, driven by supportive government policies, and groundbreaking healthcare developments.
Advances in Biohacking Applications
The application of biohacking is rapidly broadening, branching into several niches including gene editing, cognitive enhancements through smart drugs, and advanced monitoring, as industry players unveil cutting-edge technologies. One such innovation includes wearable devices purpose-built for detailed physiological monitoring - an advancement that could reshape personal health management.
Market Outlook
The biohacking landscape is ablaze with innovations set to redefine traditional Healthcare paradigms. As developers strive to unveil increasingly sophisticated biohacking tools - from smart wearables to apps, there is conviction that the impending years will further entrench biohacking within mainstream health culture.
An intensified focus on personalization in healthcare, alongside the escalation of chronic conditions and the desire for enhanced life quality, propels the market's forward trajectory.
Companies Mentioned
- TrackMyStack
- Apple Inc.
- Thync Global Inc.
- HVMN Inc.
- Muse (Interaxon Inc.)
- OsteoStrong
- The ODIN
- Moodmetric
- Thriveport LLC
- Fitbit Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value (USD) in 2023 | $26.28 Billion |
| Forecasted Market Value (USD) by 2034 | $185.13 Billion |
| Compound Annual Growth Rate | 19.4% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/2omp9v
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
